PDE3A - phosphodiesterase 3A Gene

Felis catus

Gene ID: 101088586 | Gene type: protein coding

About PDE3A

mRNA	Protein	Name
XM_045061472.1	XP_044917407.1	cGMP-inhibited 3',5'-cyclic phosphodiesterase A isoform X2
XM_019834634.3	XP_019690193.3	cGMP-inhibited 3',5'-cyclic phosphodiesterase A isoform X1
XM_045061473.1	XP_044917408.1	cGMP-inhibited 3',5'-cyclic phosphodiesterase A isoform X3

Protein Preferred Names

Protein Names

cGMP-inhibited 3',5'-cyclic phosphodiesterase A

Clinical Phase

Bioactive Molecules (5)

Cat. No.	Product Name	Effect	Purity	Phase
HY-112831	Osoresnontrine	Inhibitor	99.94%	Phase 2
HY-A0165	Tofisopam	Inhibitor	99.46%	Phase 2
HY-U00186	K134	Inhibitor	99.84%	Phase 2
HY-111167	AN-2898	Inhibitor	/	Phase 2
HY-145924	BAY 2666605	Inhibitor	99.74%	Phase 1

Pre-clinical Phase

Bioactive Molecules (23)

Cat. No.	Product Name	Effect	Purity	Rare Diseases
HY-101312	Cilostamide	Inhibitor	99.13%	Unkown
HY-136350	BRD9500	Modulator	98.41%	Unkown
HY-W028690	DNMDP	Inhibitor	99.46%	Unkown
HY-162730	OPB-171775	Inhibitor	99.80%	Unkown
HY-100530C	Sp-cAMPS sodium salt		99.45%	Unkown
HY-122751	(R)-DNMDP	Inhibitor	99.59%	Unkown
HY-100530B	Sp-cAMPS		/	Unkown
HY-136350B	(S)-BRD9500	Control	99.67%	Unkown
HY-N10149	Nauclefine		99.65%	Unkown
HY-110005	Sp-cAMPS triethylamine		/	Unkown
HY-112631	OPC 33540	Inhibitor	/	Unkown
HY-120945	PDE10A-IN-1	Inhibitor	/	Unkown
HY-153802	Antitumor agent-100	Inducer	/	Unkown
HY-153802A	Antitumor agent-100 hydrochloride	Inducer	/	Unkown
HY-174383	PDE3/4-IN-2	Inhibitor	/	Unkown
HY-176524S	PDE3/4-IN-3	Inhibitor	/	Unkown
HY-179503	PDE/TRPA1/CHIT1-IN-1	Inhibitor	/	Unkown
HY-181088	PDE3/4-IN-4	Inhibitor	/	Unkown
HY-181762	Multitarget AD-IN-6	Inhibitor	/	Unkown
HY-RS10216	PDE3A Human Pre-designed siRNA Set A	Pre-designed Set	/	Unkown
HY-RS10217	Pde3a Mouse Pre-designed siRNA Set A	Pre-designed Set	/	Unkown
HY-RS10218	Pde3a Rat Pre-designed siRNA Set A	Pre-designed Set	/	Unkown
HY-162730R	OPB-171775 (Standard)	Inhibitor	/	Unkown

Species	Symbol	Source	ID
Homo sapiens	PDE3A	NCBI	NCBI:5139

Name
Email *

	Sorry, but the email address you supplied was invalid.